Cardiolite - 11994-001-55 - (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE)

Alphabetical Index


Drug Information of Cardiolite

Product NDC: 11994-001
Proprietary Name: Cardiolite
Non Proprietary Name: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Active Ingredient(s): 1    mg/mL & nbsp;   TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Cardiolite

Product NDC: 11994-001
Labeler Name: Lantheus Medical Imaging, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019785
Marketing Category: NDA
Start Marketing Date: 19901220

Package Information of Cardiolite

Package NDC: 11994-001-55
Package Description: 5 VIAL in 1 BOX (11994-001-55) > 5 mL in 1 VIAL

NDC Information of Cardiolite

NDC Code 11994-001-55
Proprietary Name Cardiolite
Package Description 5 VIAL in 1 BOX (11994-001-55) > 5 mL in 1 VIAL
Product NDC 11994-001
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19901220
Marketing Category Name NDA
Labeler Name Lantheus Medical Imaging, Inc.
Substance Name TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Strength Number 1
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of Cardiolite


General Information